Still Video 1

€10.6 million for innovative toolboxes to tackle brain cancer


Researchers at the University of Amsterdam, Leiden University, the Netherlands Cancer Institute, and Oncode Institute have received a €10,6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma, a deadly primary brain tumor for which no curative therapy is available at the moment. At the heart of the proposed method are enzyme-mimicking molecular catalysts capable of producing different type of anti-cancer drugs within the tumor tissue itself. According to Joost Reek, professor of Supramolecular Catalysis at the University of Amsterdam (UvA) and coordinator of the ‘Cat4CanCenter’ research, this new approach could potentially solve many of the difficulties associated with the current treatment of glioblastoma.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.